GSK bolts-on immuno-oncology candidate with €3.7bn Merck dealGlaxoSmithKline is making another big play in cancer, signing a wide-ranging deal with Merck KGaA for M7824, an Share XGSK bolts-on immuno-oncology candidate with €3.7bn Merck dealhttps://pharmaphorum.com/news/gsk-bolts-on-immuno-oncology-candidate-with-e3-7bn-merck-deal/
FDA finally approves Mylan’s Advair genericThe FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler, after years of Share XFDA finally approves Mylan’s Advair generichttps://pharmaphorum.com/news/fda-finally-approves-mylans-advair-generic/
AZ’s new COPD inhaler Bevespi Aerosphere approved in EUAstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic Share XAZ’s new COPD inhaler Bevespi Aerosphere approved in EUhttps://pharmaphorum.com/news/astrazeneca-copd-bevespi-aerosphere/
GSK/Pfizer form consumer health joint ventureGlaxoSmithKline has announced its second major deal this month, signing an agreement with Pfizer to combine its consumer Share XGSK/Pfizer form consumer health joint venturehttps://pharmaphorum.com/news/gsk-pfizer-form-consumer-health-joint-venture/
GSK begins clinical trials of pancreatic cancer combinationGlaxoSmithKline plans to carry out clinical trials on its pancreatic drug hopeful, GSK547, following promising results when treating Share XGSK begins clinical trials of pancreatic cancer combinationhttps://pharmaphorum.com/news/gsk-begins-clinical-trials-of-pancreatic-cancer-combination/
AZ to continue with investment freeze following ‘no deal’ BrexitAstraZeneca will keep manufacturing investments in Britain on hold if the UK’s negotiations with Brussels fail to provide Share XAZ to continue with investment freeze following ‘no deal’ Brexithttps://pharmaphorum.com/news/az-to-continue-with-investment-freeze-following-no-deal-brexit/
Digital health round-up: Pfizer appoints chief digital officer and morePfizer has appointed a chief digital officer because of the growing importance of digital technology in its R&D Share XDigital health round-up: Pfizer appoints chief digital officer and morehttps://pharmaphorum.com/views-and-analysis/digital-health-round-up-pfizer-appoints-chief-digital-officer-and-more/
Calls for ‘Sunshine Act’ as GSK pays doctors to promote drugs againGlaxoSmithKline (GSK) will pay some doctors for promoting its drugs reversing its previous policy, sparking new calls for Share XCalls for ‘Sunshine Act’ as GSK pays doctors to promote drugs againhttps://pharmaphorum.com/news/calls-for-sunshine-act-as-gsk-pays-doctors-to-promote-drugs-again/
GSK TB vaccine shows promise, but more trials neededGlaxoSmithKline’s experimental TB vaccine has shown that it could help prevent the disease, but further research is needed Share XGSK TB vaccine shows promise, but more trials neededhttps://pharmaphorum.com/news/gsk-tb-vaccine-shows-promise-but-more-trials-needed/
